1545P CS2009, a novel PD-1/VEGF/CTLA-4 trispecific antibody, in patients with advanced solid tumors: An open-label, multicenter, phase I first-in-human study.
Saved in:
| Title: | 1545P CS2009, a novel PD-1/VEGF/CTLA-4 trispecific antibody, in patients with advanced solid tumors: An open-label, multicenter, phase I first-in-human study. |
|---|---|
| Authors: | Lemech, C.1 (AUTHOR), Coward, J.2 (AUTHOR), Gao, B.3 (AUTHOR), Park, J.J.W.4 (AUTHOR), Zhou, C.5 (AUTHOR), Moore, M.6 (AUTHOR), Frentzas, S.7 (AUTHOR), Gan, H.K.8 (AUTHOR), Wang, J.9 (AUTHOR), Wang, Q.9 (AUTHOR), Fang, T.9 (AUTHOR), Dai, H.9 (AUTHOR), Yue, Z.9 (AUTHOR), La, Y.10 (AUTHOR), Shi, Q.9 (AUTHOR), Yang, J.J.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS923-S923. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2176 |
